WHO Backs GLP-1 Drugs & Samagra Shiksha Scheme Update

Daily Current Affairs / WHO Backs GLP-1 Drugs & Samagra Shiksha Scheme Update

Change Language English Hindi

Category : National Published on: December 06 2025

Share on facebook

The World Health Organization (WHO) released its first guideline on GLP-1 (Glucagon-Like Peptide-1) therapies for obesity treatment, adding them to the Essential Medicines List for high-risk type 2 diabetes patients. GLP-1 drugs like liraglutide, semaglutide, and tirzepatide help in weight loss, lower heart disease risks and prevent diabetes, but counterfeit products pose safety concerns. Meanwhile, Union Education Minister Dharmendra Pradhan emphasized that states must meet conditions under the Samagra Shiksha Scheme to receive central funds, promoting equitable and quality education aligned with NEP 2020.

Dec 26

Dec 26

Dec 26

Dec 24

Dec 23

WHO Backs GLP-1 Drugs & Samagra Shiksha Scheme Update

Recent Post's

Notification view all

Dec 26

Dec 26

Dec 26

Dec 24

Dec 23

WHO Backs GLP-1 Drugs & Samagra Shiksha Scheme Update

Recent Post's

Notification
view all